Medicine

Accelerating ASO treatments from progression to execution

.Contending enthusiasms.R.S., M.S., H.G. and also A.A.R. are actually planners of the 1M1M initiative. H.G. and also A.A.R. are board of supervisors members as well as R.S., M.S. and also A.A.R. are actually members of the medical consultatory board of N1C. A.A.R. discloses work by LUMC, which possesses patents on exon-skipping modern technology, a few of which has actually been actually licensed to BioMarin and also consequently sublicensed to Sarepta. As co-inventor of some of these patents, A.A.R. was actually allowed to a share of nobilities. A.A.R. further discloses working as impromptu consultant for PTC Therapeutics, Sarepta Therapies, Regenxbio, Dyne Therapeutics, Lilly, BioMarin Pharmaceuticals Inc., Eisai, Entrada, Takeda, Splicesense, Galapagos, Sapreme, Italfarmaco and also Astra Zeneca. Previously 5 years, A.A.R. additionally executed ad hoc speaking with for Alpha Anomeric. A.A.R. additionally mentions registration of the scientific advisory boards of Eisai, Hybridize Therapeutics, Silence Rehabs, Sarepta Rehabs, Sapreme and also Mitorx. Over the last 5 years, A.A.R. was also a medical advisory board member for ProQR. Pay for A.A.R. u00e2 s consulting as well as recommending activities is paid to LUMC. Over the last 5 years, LUMC also received sound speaker gratuity coming from PTC Therapies, Alnylam Netherlands, Italfarmaco as well as Pfizer and also cashing for agreement study from Sapreme, Eisai, Galapagos, Synaffix as well as Alpha Anomeric. Project funding is obtained from Sarepta Rehabs as well as Entrada by means of unlimited grants. H.G. possesses nothing at all to make known in regard to the subjects dealt with in this particular composition. Before 5 years, he has likewise obtained working as a consultant honoraria from UCB. M.S. received consultancy gratuity coming from Ionis, UCB, Prevail, Orphazyme, Biogen, Servier, Reata, GenOrph, AviadoBio, Biohaven, Zevra, Lilly and also Solaxa over the last 5 years, all unassociated to the present composition. R.S. possesses nothing to make known in connection with the topics dealt with within this document. She has gotten audio speaker and/or working as a consultant gratuity or even financing payments coming from Abbvie, Bial, STADA as well as Everpharma before 5 years.

Articles You Can Be Interested In